reported decreased ITGB7 expression in tumor-infiltrating CD8+T cells, with higher expression correlating with improved survival in colorectal cancer patients, suggesting its role in sustaining antitumor immune cell infiltration and inhibiting tumor progression (49). Here, ITGB7 is linked to neoplasm.